PD-L1 and PD-L2 protein expression was analyzed in 32 tumors from 31 female patients, including 23 (71.9%) ER+ BC and 9 (28.1%) TNBC, with 1 patient having multifocal unilateral ER+ BC. This evidence concerns the gene PDCD1LG2 and breast cancer.